As IL-6 plays an integral role in the development of hepatocyte inflammation, liver disease, and liver cancers, the utilization of the MAPK-ERK during HBV infection may highlight a potential role of this pathway facilitating the development of HCC and other liver cancers in vivo. Here, IL6 is linked to liver cancer.